Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: A cross-sectional study in psoriasis from Hungary

European Journal of Health Economics

Volumn 15, Issue SUPPL. 1, 2014, Pages

  Herédi, Emese ^a   Rencz, Fanni ^b,c   Balogh, Orsolya ^b   Gulácsi, László ^b   Herszényi, Krisztina ^c   Holló, Péter ^c   Jókai, Hajnalka ^c   Kárpáti, Sarolta ^c   Péntek, Márta ^b   Remenyik, Éva ^a   Szegedi, Andrea ^a   Brodszky, Valentin ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Institute of Data Analytics and Information Systems   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

DLQI; EQ 5D; Mapping; Psoriasis; Quality of life

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BIOLOGICAL THERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HEALTH CARE SURVEY; HEALTH CARE UTILIZATION; HUMAN; HUNGARY; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; AGED; CLASSIFICATION; MIDDLE AGED; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HUNGARY; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84905637902     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0600-x     Document Type: Article

References (31)

1. Parisi, R., Symmons, D.P., Griffiths, C.E., Ashcroft, D.M.: Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J. Invest. Dermatol. 133(2), 377-385 (2013). doi:10.1038/jid.2012.339
2. de Korte, J., Sprangers, M.A., Mombers, F.M., Bos, J.D.: Quality of life in patients with psoriasis: a systematic literature review. J. Investig. Dermatol. Symp. Proc. 9(2), 140-147 (2004). doi:10.1046/j.1087-0024.2003.09110.x
3. Ahn, C.S., Gustafson, C.J., Sandoval, L.F., Davis, S.A., Feldman, S.R.: Cost effectiveness of biologic therapies for plaque psoriasis. Am. J. Clin. Dermatol. 14(4), 315-326 (2013). doi:10.1007/s40257-013-0030-z
4. Brodszky, V.: Systematic Review and Analysis of Evidences on Clinical Efficacy and Cost-Effectiveness of Biological Drugs for the Treatment of Prosiasis. Corvinus University of Budapest, Department of Health Economics, Budapest, Hungary (2013)
5. Bronsard, V., Paul, C., Prey, S., Puzenat, E., Gourraud, P.A., Aractingi, S., Aubin, F., Bagot, M., Cribier, B., Joly, P., Jullien, D., Le Maitre, M., Richard-Lallemand, M.A., Ortonne, J.P.: What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J. Eur. Acad. Dermatol. Venereol. 24(Suppl 2), 17-22 (2010). doi:10.1111/j.1468-3083.2009.03563.x
6. Lewis, V., Finlay, A.Y.: 10 years experience of the Dermatology Life Quality Index (DLQI). J. Investig. Dermatol. Symp. Proc. 9(2), 169-180 (2004). doi:10.1111/j.1087-0024.2004.09113.x
7. Dakin, H.: Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual. Life Outcomes 11, 151 (2013). doi:10.1186/1477-7525-11-151
8. Norlin, J.M., Steen Carlsson, K., Persson, U., Schmitt-Egenolf, M.: Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients. Br. J. Dermatol. 166(4), 797-802 (2012). doi:10.1111/j.1365-2133.2011.10778.x
9. Blome, C., Beikert, F.C., Rustenbach, S.J., Augustin, M.: Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities. Arch. Dermatol. Res. 305(3), 197-204 (2013). doi:10.1007/s00403-012-1309-2
10. Currie, C.J., Conway, P.: Evaluation of the association between EQ5D utility and dermatology life quality index (DLQI) score in patients with psoriasis. Value Health 10(6), A470 (2007)
11. Hjortsberg, C., Bergman, A., Bjarnason, A., Heikkila, H., Hjelmgren, J., Svensson, A., Tennvall, G.R.: Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm. Venereol. 91(4), 409-414 (2011). doi:10.2340/00015555-1094
12. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35(11), 1095-1108 (1997)
13. Finlay, A.Y., Khan, G.K.: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin. Exp. Dermatol. 19(3), 210-216 (1994)
14. Basra, M.K., Fenech, R., Gatt, R.M., Salek, M.S., Finlay, A.Y.: The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br. J. Dermatol. 159(5), 997-1035 (2008). doi:10.1111/j.1365-2133.2008.08832.x
15. Cohen, J.: A power primer. Psychol. Bull. 112, 155-159 (1992)
16. Balogh, O., Brodszky, V., Gulácsi, L., Herédi, E., Herszényi, K., Jókai, H., Kárpáti, S., Baji, P., Remenyik, É., Szegedi, A., Holló, P.: Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres. Eur. J. Health Econ. (2014). doi:10.1007/s10198-014- 0599-z
17. Mabuchi, T., Yamaoka, H., Kojima, T., Ikoma, N., Akasaka, E., Ozawa, A.: Psoriasis affects patient's quality of life more seriously in female than in male in Japan. Tokai J. Exp. Clin. Med. 37(3), 84-88 (2012)
18. Nijsten, T., Meads, D.M., de Korte, J., Sampogna, F., Gelfand, J.M., Ongenae, K., Evers, A.W., Augustin, M.: Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J. Invest. Dermatol. 127(10), 2315-2322 (2007). doi:10.1038/sj.jid. 5700875
19. Mattei, P.L., Corey, K.C., Kimball, A.B.: Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J. Eur. Acad. Dermatol. Venereol. (2013). doi:10.1111/jdv.12106
20. Robinson, A., Kardos, M., Kimball, A.B.: Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. J. Am. Acad. Dermatol. 66(3), 369-375 (2012). doi:10.1016/j.jaad.2011.01.022
21. Revicki, D.A., Jin, Y., Wilson, H.D., Chau, D., Viswanathan, H.N.: Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis. J. Dermatolog. Treat. 25(1), 8-14 (2014). doi:10.3109/09546634.2013.769042
22. Dauden, E., Herrera, E., Puig, L., Sanchez-Carazo, J.L., Toribio, J., Caloto, M.T., Nocea, G., Roset, M., Lara, N.: Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Health Qual. Life Outcomes 10, 56 (2012). doi:10.1186/1477-7525-10-56
23. Brodszky, V., Pentek, M., Balint, P.V., Geher, P., Hajdu, O., Hodinka, L., Horvath, G., Koo, E., Polgar, A., Sesztak, M., Szanto, S., Ujfalussy, I., Gulacsi, L.: Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand. J. Rheumatol. 39(4), 303-309 (2010). doi:10.3109/03009740903468982
24. Dauden, E., Herrera, E., Puig, L., Sanchez-Carazo, J.L., Toribio, J., Perulero, N.: Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study. Actas Dermosifiliogr. 104(8), 685-693 (2013). doi:10.1016/j.adengl.2013.02.008
25. Pettey, A.A., Balkrishnan, R., Rapp, S.R., Fleischer, A.B., Feldman, S.R.: Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J. Am. Acad. Dermatol. 49(2), 271-275 (2003)
26. Sampogna, F., Tabolli, S., Abeni, D.: Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm. Venereol. 92 (3), 299-303 (2012). doi:10.2340/00015555-1273
27. Sampogna, F., Chren, M.M., Melchi, C.F., Pasquini, P., Tabolli, S., Abeni, D.: Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br. J. Dermatol. 154(2), 325-331 (2006). doi:10.1111/j.1365-2133.2005.06909.x
28. Lesuis, N., Befrits, R., Nyberg, F., van Vollenhoven, R.F.: Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med. 10, 82 (2012). doi:10.1186/1741-7015-10-82
29. Lu, G., Brazier, J.E., Ades, A.E.: Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model. Value Health 16(1), 177-184 (2013). doi:10.1016/j.jval.2012.07.003
30. Brazier, J.E., Yang, Y., Tsuchiya, A., Rowen, D.L.: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur. J. Health Econ. 11(2), 215-225 (2010). doi:10.1007/s10198-009-0168-z
31. Shikiar, R., Willian, M.K., Okun, M.M., Thompson, C.S., Revicki, D.A.: The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual. Life Outcomes 4, 71 (2006). doi:10.1186/1477-7525-4-71 Research Fund Research Fund